Related Experiment Video
Updated: May 21, 2026

Protein Target Prediction and Validation of Small Molecule Compound
Published on: February 23, 2024
Modulating protein-protein interactions: from structural determinants of binding to druggability prediction to
Alexander Metz1, Emanuele Ciglia, Holger Gohlke
1Institute for Pharmaceutical and Medicinal Chemistry, Department of Mathematics and Natural Sciences, Heinrich-Heine-University, Düsseldorf, Germany.
Protein-protein interactions are crucial for biological processes and diseases. Recent advances show these interactions are druggable targets, offering new therapeutic potential for various conditions.
Area of Science:
- Biochemistry
- Pharmacology
- Computational Biology
Background:
- Protein-protein interactions (PPIs) are vital for biological processes.
- Dysregulated PPIs are implicated in numerous diseases.
- Modulating PPIs presents a promising therapeutic strategy.
Purpose of the Study:
- To review the characteristics of protein-protein interfaces.
- To discuss the druggability of PPIs and relevant drug design strategies.
- To present case studies of PPI modulation.
Main Methods:
- Analysis of protein-protein interface features.
- Exploitation of PPI characteristics in drug design.
- Application of computational methods for identifying PPI modulators.
- Case study analysis (HDM2, IL-2, NHR2).
Main Results:
- PPI interfaces differ significantly from classical ligand-binding sites.
- PPIs are druggable targets with therapeutic potential.
- Computational approaches are effective in identifying PPI modulators.
Conclusions:
- PPIs represent a valuable class of therapeutic targets.
- Drug discovery strategies can be adapted for PPI modulation.
- Computational methods are instrumental in advancing PPI-targeted therapies.
More Related Videos
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
06:50Computational Prediction of Amino Acid Preferences of Potentially Multispecific Peptide-Binding Domains Involved in Protein-Protein Interactions
Published on: January 26, 2024
Related Concept Videos
Protein-protein Interfaces
Protein-Protein Interfaces
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...